Inclusion compounds of indomethacin with hydroxypropyl-β-cyclodextrin. Dissolution profile and partition coefficient evaluation;Complexos de inclusão de indometacina com hidroxipropil-β- ciclodextrina. Estudos de dissolução e coeficiente de partição

Revista Brasileira de Ciencias Farmaceuticas/Brazilian Journal of Pharmaceutical Sciences

Volumn 42, Issue 1, 2006, Pages 59-68

  Rama, Ana Cristina Ribeiro ^a   Veiga, Francisco ^a,b   Figueiredo, Isabel Vitória ^a   Sousa, Adriano ^a   Caramona, Margarida ^a  

^a UNIVERSITY OF COIMBRA   (Portugal)

^b UNIVERSITY OF COIMBRA   (Portugal)

Author keywords

Dissolution; Hydroxypropyl cyclodextrin; Indomethacin; Partition coefficient

Indexed keywords

2 HYDROXYPROPYL BETA CYCLODEXTRIN; INDOMETACIN;

ARTICLE; DRUG SOLUBILITY; FREEZE DRYING; HYDROLYSIS; PARTITION COEFFICIENT; PH;

EID: 33745927405     PISSN: 15169332     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. AMIDON, G.L.; LENNERNÃS, H.; SHAH, V.P.; CRISON, J.R. A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability. Pharm. Res., New York, v.12, n.3, p.413-420, 1995.
2. BARRETO, M.; BICA, A.; FARINHA, A. Sistemas de classificação biofarmacêutica. Bol. LEF., Lisboa, v.32, p.2-10, 2002.
3. BESUNDER, J.B.; REED, M.D.; BLUMER, J.L. Principles of drug biodisposition, in the neonate. A critical evaluation of the pharmacokinetic-pharmacodynamic interface (part I). Clin. Pharmacokinet., Auckland, v.14, p.189-216, 1988.
4. BURI, P. Préformulation: pKa et coefficient de partage. Labo-Pharma-Problémes et Techniques., Paris, v.307, p.181-186, 1981.
5. CHOWDARY, K.P.R.; SURESH BABU, K.V.V. Dissolution, bioavailability and ulcerogenic studies on solid dispersions of indomethacin in water soluble cellulose polymers. Drug Dev. Ind. Pharm., New York, v.20, n.5, p.799-813, 1994.
6. CONTI, B.; GENTA, I.; GIUNCHEDI, P.; MODENA, T. Testing of "in vitro" dissolution behaviour of microparticulate drug delivery systems. Drug Dev. Ind. Pharm., New York, v.21, n.10, p.1223-1233, 1995.
7. DRESSMAN, J.B.; AMIDON, G.L.; REPPAS, C.; SHAH, V.P. Dissolution testing as a prognostic tool for oral drug absorption: immediate release dosage forms. Pharm. Res., New York, v.15, n.1, p.11-22, 1998.
8. FORD, J.L.; RAJABI-SIAHBOOMI, A.R. Dissolution and dissolution testing. In: SWARBRICK, J.; BOYLAN, J.C. Encyclopedia of pharmaceutical technology. 2nd ed. v.1, New York; Basel: Marcel Dekker, Inc., p.717-728, 2002.
9. FRIJLINK, H.W.; SCHOONEN, A.J.M.; LERK, C.F. The effects of cyclodextrins on drug absorption I: in vitro observations. Int. J. Pharm., Amsterdam, v.49, p.91-102, 1989.
10. KINGSFORD, M.; EGGERS, N.J.; SOTEROS, G.; MALING, T.J.B.; SHIRKEY, R.J. An in-vivo - in-vitro correlation for the bioavailability of frusemide tablets. J. Pharm. Pharmacol., London, v.36, p.536-538, 1984.
11. LA ROTONDA, M.I.; CAPPELLO, B.; GRIMALDI, M., SILIPO, C.; VITTORIA, A. Analisi correlativa fra bilancio idrofilo-lipofilo, coefficiente di diffusione e concentrazione idrogenionica in una serie di farmaci antiinfiammatori non steroidei. Farmaco., Pavia, v.43, n.5, p.439-455, 1988.
12. LEO, A.; HANSCH, C.; ELKINS, D. Partition coefficients and their uses. Chem. Rev., Washington, v.71, n.6, p.525-616, 1971.
13. LIEN, E.J.; REN, S. Partition Coefficients. In SWARBRICK, J.; BOYLAN, J.C. Encyclopedia of pharmaceutical technology. 2nd ed. v.2, New York; Basel: Marcel Dekker, Inc., 2002. p.2012-2019.
14. LIN, S.Y.; KAO, Y.H. Solid particles of drug-beta-CD inclusion complexes directly prepared by a spray-drying technique. Int. J. Pharm., Amsterdam, v.56, p.249-259, 1989.
15. NAKAJIMA, T.; SUNAGAWA, M.; HIROHASHI, T. Studies of cyclodextrin inclusion complexes. II. Application of the partition coefficient method. Chem. Pharm. Bull, Tokyo, v.32, n.2, p.401-408, 1984.
16. PANCHAGNULA, R.; THOMAS, N.S. Biopharmaceutics and pharmacokinetics in drug research. Int. J. Pharm., Amsterdam, v.201, p.131-150, 2000.
17. RIBEIRO-RAMA, A. C. Diminuição de toxicidade gástrica da indometacina por complexação com hidroxipropil-β- ciclodextrina. Coimbra, 2003. [Dissertação de mestrado. Faculdade de Farmácia, Universidade de Coimbra].
18. SHARGEL, L.; YU A.B.C. Biopharmaceutics. In SWARBRICK, J.; BOYLAN, J.C. Encyclopedia of pharmaceutical technology. 2nd ed. vol. 1. New York; Basel: Marcel Dekker, Inc., 2002. p.156-176.
19. UEKAMA, K.; UEMURA, Y.; IRIE, T.; OTAGIRI, M. Analysis of interfacial transfer and absorption behaviour of drugs following dissolution from β-cyclodextrin complexes. Chem. Pharm. Bull., Tokyo, v.31, n.10, p.3637-3643, 1983.
20. VEIGA, F. Complexos de inclusão com ciclodextrinas hidrófilas. Caracterização físico-química e biofarmacêutica. Coimbra, 1996. [Tese de doutoramento, Faculdade de Farmácia, Universidade de Coimbra].
21. YAZAN, Y.; SUMNU, M. Improvement in the dissolution properties of theophylline with β-cyclodextrin. S.T.P. Pharma Sci., Paris, v.4, n.2, p.128-132, 1994.
22. YOSHIOKA, H.; ISEKI, K.; FUJITA, K. Development and differences of intestinal flora in the neonatal period in breast-fed and bottle-fed infants. Pediatrics, Evaston, v.72, n.3, p.317-321, 1983.